Effects of Short-Course Zidovudine on the Selection of Nevirapine-Resistant HIV-1 in Women Taking Single-Dose Nevirapine Full Text
The Journal of Infectious Diseases, 05/07/2012
Micek MA et al. – NVP mutants decayed to <2% in 24/35 (68.6%) at a median 6 months postpartum, with no differences based on ZDV use. Short–course zidovudine (ZDV) was associated with reduced NVP–resistance mutations among women taking sdNVP.